XML 27 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share Based Compensation (Details) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Performance-based compensation plan [Member]
Mar. 31, 2013
Performance-based compensation plan [Member]
Mar. 31, 2014
Stock Options [Member]
Mar. 31, 2014
Non-Vested Restricted Stock, Restricted Stock Units and PSU's [Member]
Mar. 31, 2014
Director [Member]
Mar. 31, 2013
Director [Member]
Dec. 31, 2013
Chief Executive Officer [Member]
Mar. 31, 2014
Non-Employee Directors [Member]
Mar. 31, 2013
Non-Employee Directors [Member]
Mar. 31, 2014
Officers [Member]
Restricted Stock [Member]
Performance-based compensation plan [Member]
Mar. 31, 2014
Officers [Member]
Performance stock units [Member]
Performance-based compensation plan [Member]
Share based compensation arrangements [Line Items]                          
Number of additional shares approved for grant (in shares) 400,000                 200,000      
Number of stock units or restricted shares issued in period (in shares)       0               70,000 30,000
Vesting period                       3 years 3 years
Shares issues as retainer fees (in shares)             4,000 24,000          
Annual salary                 $ 20,000        
Total compensation expense (recovery) recognized     200,000 100,000           50,000 90,000    
Tax benefit relating to compensation expense recognized     100,000 0           20,000 0    
Total compensation cost not yet recognized 2,300,000                        
Total compensation cost not yet recognized, period for recognition 2 years 4 months 24 days                        
Outstanding stock option grants and transaction [Roll Forward]                          
Outstanding, beginning balance (in shares)         320,300                
Granted (in shares)         0                
Exercised (in shares)         (1,935)                
Forfeited (in shares)         (2,401)                
Expired (in shares)         (284)                
Outstanding, ending balance (in shares)         315,680                
Vested and expected to vest, period end (in shares)         303,702                
Exercisable, period end (in shares)         131,297                
Weighted Average Exercise Price [Roll Forward]                          
Outstanding, beginning balance (in dollars per share)         $ 4.52                
Exercised (in dollars per share)         $ 5.25                
Forfeited (in dollars per share)         $ 4.12                
Expired (in dollars per share)         $ 3.46                
Outstanding, ending balance (in dollars per share)         $ 4.52                
Vested and expected to vest, period end (in dollars per share)         $ 4.52                
Exercisable, period end (in dollars per share)         $ 5.13                
Weighted-Average Remaining Contractual Term [Abstract]                          
Outstanding, Weighted Average Remaining Contractual Term         7 years 10 months 2 days                
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term         7 years 9 months 18 days                
Exercisable, Weighted Average Remaining Contractual Term         6 years 10 months 28 days                
Aggregate intrinsic value [Abstract]                          
Outstanding, Intrinsic Value         2,749,000                
Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value         2,649,000                
Exercisable, Aggregate Intrinsic Value         1,108,000                
Number of Shares [Roll Forward]                          
Outstanding, beginning balance (in shares)           303,980              
Granted (in shares)           101,104              
Vested (in shares)           0              
Forfeited (in shares)           0              
Outstanding, ending balance (in shares)           405,084              
Weighted Average Grant Date Fair Value [Roll Forward]                          
Outstanding, beginning balance (in dollars per share)           $ 3.77              
Granted (in dollars per share)           $ 13.86              
Outstanding, ending balance (in dollars per share)           $ 6.29              
Information regarding options exercised [Abstract]                          
Intrinsic value 15,000 15,000                      
Cash proceeds received 10,000 11,000                      
Tax benefit realized $ 5,000 $ 0